| Phase 1 Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with Retinal Disease due to MERTK Mutations |
Completed |
rAAV2-VMD2-hMERTK |
1 |
rAAV2-VMD2-hMERTK |
King Faisal Specialist Hospital and Research Center (Riyadh), King Khaled Eye Specialist Hospital (Riyadh) |
| Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Slow Repeated IV Infusions of 2 Doses of Doxorubicin Transdrug™ (DT) (20mg/m2 and 30mg/m2) to Those of Best Standard of Care (BSC) in Patients With Advanced Hepatocellular Carcinoma (HCC) After Failure or Intolerance to Sorafenib. ReLive Study. |
Completed |
Doxorubicin |
3 |
BA2011/03/04 |
King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Jeddah) |
| "An open-label extension study of the long-term safety,tolerability and efficacy of Ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension(CTEPH)." |
Terminated |
Ambrisentan |
3 |
116457 |
King Fahad Medical City (Riyadh) |
| A Compartive Multicenter Study of Neoadjuvant Docetaxel/Cisplatin Followed by Concurrent Cisplatin with Radiotherapy using Intensity-Modulated Radition Therapy (IMRT) with or without Bevacizumab for Locally Advanced Nasopharyngeal Cancer |
Terminated |
Docetaxel/Cisplatin and Bevacizumab |
3 |
Version 1.3 date 6 may 2012 |
King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh) |
| "A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus" |
Terminated |
MK-0431A (Sitagliptin / Metformin) vs Liraglutide |
3 |
MK-0431A-180-00 |
King Khalid University Hospital (Riyadh) |
| Efficacy of lntra-cervical Misoprostol in the Management of Early Pregnancy Failure: Randumized Clinical Trial |
Rejected |
Misoprostol |
2 |
227-15 |
King Abdulaziz University Hospital (Jeddah) |
| An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients |
Completed |
Travoprost 0.004% |
1 |
C-12-009 |
King Khaled Eye Specialist Hospital (Riyadh) |
| "Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients" |
Completed |
• Micafungin• Fluconazole• Liposomal Amphotericin B• Caspofungin |
3b |
9463EC0001 |
King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease. |
Terminated |
Prasugrel |
3 |
H7T-MC-TADO |
King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh) |
| A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) |
Terminated |
Lutropin alfa |
3b |
EMR200061_506 |
King Abdulaziz University Hospital (Jeddah) |
